Presentation is loading. Please wait.

Presentation is loading. Please wait.

Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations  Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,

Published byλατίνος Καρράς Modified over 5 years ago

Similar presentations

Presentation on theme: "Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations  Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,"— Presentation transcript:

1 Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations 
Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai, MD, Peng-Zhi Ni, MD, Long-Qi Chen, MD, PhD  The Annals of Thoracic Surgery  Volume 101, Issue 1, Pages (January 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Percentage of patients with examined and positive nodes in each station. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Scatter plot of number of metastatic lymph node (LN) stations on x-axis versus Martingale residuals for the 1,351 patients with esophageal squamous cell carcinoma (ESCC). Patients above horizontal line (zero) were at increased risk for death compared with expected risk from Cox proportional hazards regression model. Patients below the horizontal line (zero) were at decreased risk for death compared with expected risk. Curved line represents smoother scatter plot. Curved line crosses horizontal line at 1 metastatic LN station, indicating that this would be best cutoff point to predict death from esophageal carcinoma. Point at which curved line reaches platform is at 4 metastatic LN stations, indicating that this would be another cutoff point. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 (A) Overall survival by the nodal category of seventh American Joint Committee on Cancer (AJCC) tumor, node, metastasis (TNM) staging system (N0 versus N1, N2, N3: p < 0.001; N1 versus N2: p = 0.003; N1 versus N3: p = 0.001; N2 versus N3: p = 0.103). (B) Overall survival by revised nodal categories based on number of metastatic lymph node stations (rN0 versus rN1, rN2, rN3: p < 0.001; rN1 versus rN2: p = 0.001; rN1 versus rN3: p < 0.001; rN2 versus rN3: p = 0.001). (C) Overall survival by original seventh AJCC TNM staging system (overall log rank: p < 0.001; stage IIIA versus stage IIIB, p = 0.021; stage IIIA versus stage IIIC, p < 0.001; stage IIIB versus stage IIIC, p = 0.118). (D) Overall survival by the modified TNM staging system (overall log rank: p < 0.001; stage IIIA versus stage IIIB, p = 0.040; stage IIIA versus stage IIIC, p < 0.001; stage IIIB versus stage IIIC, p = 0.007). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations  Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,"

Similar presentations

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.
Resection of Esophageal Carcinoma During Pregnancy

Resection of Esophageal Carcinoma During Pregnancy
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?  Dongrong Situ, MD, Junye Wang, MD, PhD, Peng Lin, MD, PhD,

Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?  Dongrong Situ, MD, Junye Wang, MD, PhD, Peng Lin, MD, PhD,
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,
Chun Chieh Lin, PhD, MBA, Matthew P

Chun Chieh Lin, PhD, MBA, Matthew P
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Collision Tumor of Esophagus: Report of Three Cases

Collision Tumor of Esophagus: Report of Three Cases
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma  Tianxiang Chen, MD, PhD, Jizhuang Luo, MD, Haiyong.

Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma  Tianxiang Chen, MD, PhD, Jizhuang Luo, MD, Haiyong.
A Strategy for Supraclavicular Lymph Node Dissection Using Recurrent Laryngeal Nerve Lymph Node Status in Thoracic Esophageal Squamous Cell Carcinoma 

A Strategy for Supraclavicular Lymph Node Dissection Using Recurrent Laryngeal Nerve Lymph Node Status in Thoracic Esophageal Squamous Cell Carcinoma 
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Andrew Feber, PhD, Liqiang Xi, MD, PhD, Arjun Pennathur, MD, William E

Andrew Feber, PhD, Liqiang Xi, MD, PhD, Arjun Pennathur, MD, William E
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Similar presentations

Ads by Google